Clinical Programs
Pervasis is committed to advancing the next generation of breakthrough products that can improve patient outcomes following surgical or interventional procedures. Our lead development programs are focused on two areas: improving vascular access procedures for hemodialysis patients, and reducing complications following angioplasty or stent implants for peripheral arterial disease.
To learn more about Pervasis’ clinical trials, please visit the link below or visit www.clinicaltrials.gov directly.